ArticlePloS one2025

Safety assessment of obinutuzumab: Real-world adverse event analysis based on the FAERS and JADER databases from 2013 to 2025.

Xiangpeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.